One year after

How has terrorism altered the landscape of life science since 9-11?

Written byChristine Soares
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

When terrorists attacked New York and Washington, DC on 11 September 2001 the physical and political impact was immediately apparent, but implications for science were less obvious. A few weeks later when another, more stealthy assault via mailed microbes was revealed, terrorism hit closer to home for US researchers. Soon it was clear that one of their own was likely behind the anthrax mailings, provoking suspicions among scientists themselves and intense scrutiny by government investigators.

Biological warfare was a hot research topic before the fall of 2001, but the threat made real and the possibility of further terrorism prompted a profusion of new rules and restrictions on how scientists conduct their work. The events of last fall also spurred expectations of a flood of funding for research that could contribute to the new 'war on terrorism'.

One year later, our reporter Peg Brickley asks whether those expectations have been fulfilled ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies